157 related articles for article (PubMed ID: 35238137)
1. Quality performance indicators for the surgical treatment of gastric adenocarcinoma: a systematic review.
Kulasegaran S; Woodhouse B; MacCormick AD; Srinivasa S; Koea J
ANZ J Surg; 2022 Sep; 92(9):1995-2002. PubMed ID: 35238137
[TBL] [Abstract][Full Text] [Related]
2. Quality performance indicator compliance for the treatment of gastric adenocarcinoma.
Wang Y; Kulasegaran S; Srinivasa S; Koea J; MacCormick A
ANZ J Surg; 2023 May; 93(5):1294-1299. PubMed ID: 36825561
[TBL] [Abstract][Full Text] [Related]
3. Quality Performance Indicators for the Surgical Management of Oesophageal Cancer: A Systematic Literature Review.
Kulasegaran S; Wang Y; Woodhouse B; MacCormick A; Srinivasa S; Koea J
World J Surg; 2023 Dec; 47(12):3262-3269. PubMed ID: 37865917
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Gastric Resection in the Establishment of a Comprehensive Oncologic Robotic Program.
Balbona J; Chen L; Malafa MP; Hodul PJ; Dineen SP; Mehta R; Mhaskar RS; Pimiento JM
J Surg Res; 2020 Aug; 252():30-36. PubMed ID: 32222591
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations.
Caruso S; Patriti A; Roviello F; De Franco L; Franceschini F; Coratti A; Ceccarelli G
World J Gastroenterol; 2016 Jul; 22(25):5694-717. PubMed ID: 27433084
[TBL] [Abstract][Full Text] [Related]
7. [Gastrectomy with radical lymphadenectomy--standard therapy of adenocarcinoma of the stomach].
Thybusch A; Schmid A; Henne-Bruns D; Kremer B
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():173-5. PubMed ID: 9101822
[TBL] [Abstract][Full Text] [Related]
8. Oncologic specimen from laparoscopic assisted gastrectomy for gastric adenocarcinoma is comparable to D1-open surgery: the experience of a Canadian centre.
Hallet J; Labidi S; Bouchard-Fortier A; Clairoux A; Gagné JP
Can J Surg; 2013 Aug; 56(4):249-55. PubMed ID: 23883495
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
10. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive gastrectomy for gastric cancer: A national perspective on oncologic outcomes and overall survival.
Leung K; Sun Z; Nussbaum DP; Adam MA; Worni M; Blazer DG
Surg Oncol; 2017 Sep; 26(3):324-330. PubMed ID: 28807254
[TBL] [Abstract][Full Text] [Related]
12. Proximal gastrectomy versus total gastrectomy for proximal third gastric cancer: total gastrectomy is not always necessary.
Sugoor P; Shah S; Dusane R; Desouza A; Goel M; Shrikhande SV
Langenbecks Arch Surg; 2016 Aug; 401(5):687-97. PubMed ID: 27143021
[TBL] [Abstract][Full Text] [Related]
13. Totally laparoscopic versus open gastrectomy for advanced gastric cancer: a matched retrospective cohort study.
Chan BYO; Yau KKW; Chan CKO
Hong Kong Med J; 2019 Feb; 25(1):30-7. PubMed ID: 30655459
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of gastric adenocarcinoma. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC).
Voron T; Romain B; Bergeat D; Véziant J; Gagnière J; Le Roy B; Pasquer A; Eveno C; Gaujoux S; Pezet D; Gronnier C; ;
J Visc Surg; 2020 Apr; 157(2):117-126. PubMed ID: 32151595
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of gastric adenocarcinoma: the role of lymph node dissection.
Lee WJ; Hsu FC; Shun CT; Lee PH; Yu SC; Chang KJ; Wang SM; Wei TC; Lee WC; Chen KM
J Formos Med Assoc; 1995 May; 94(5):221-7. PubMed ID: 7613253
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the current surgical management of gastric adenocarcinoma.
Dalton RR; Eisenberg BL
Oncology (Williston Park); 1994 Jul; 8(7):99-105; discussion 105-7. PubMed ID: 7917844
[TBL] [Abstract][Full Text] [Related]
18. The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: A multi-institutional study of the US Gastric Cancer Collaborative.
Postlewait LM; Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Swords D; Jin LX; Cho CS; Winslow ER; Cardona K; Staley CA; Maithel SK
J Surg Oncol; 2015 Aug; 112(2):203-7. PubMed ID: 26272801
[TBL] [Abstract][Full Text] [Related]
19. Entirely laparoscopic radical gastrectomy for adenocarcinoma: lymph node yield and resection margins.
Sarela AI
Surg Endosc; 2009 Jan; 23(1):153-60. PubMed ID: 18633671
[TBL] [Abstract][Full Text] [Related]
20. The influence of stage migration on the comparison of surgical outcomes between D2 gastrectomy and D3 gastrectomy (para-aortic lymph node dissection): a multi-institutional retrospective study.
Kunisaki C; Takahashi M; Fukushima T; Nagahori Y; Akiyama H; Makino H; Otsuka Y; Ono HA; Kosaka T; Takagawa R; Shimada H
Am J Surg; 2008 Sep; 196(3):358-63. PubMed ID: 18466868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
